...
首页> 外文期刊>Digestive surgery >Major Hepatectomy for Colorectal Liver Metastases in Patients Aged Over 80: A Propensity Score Matching Analysis
【24h】

Major Hepatectomy for Colorectal Liver Metastases in Patients Aged Over 80: A Propensity Score Matching Analysis

机译:80岁以上患者结肠直肠肝转移的主要肝切除术:倾向得分匹配分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: The aim of this study was to evaluate the results of major hepatectomies for metastasis in elderly colorectal cancer patients, for whom limited data exist in the literature. Methods: From January 2006 to January 2013, 3,034 patients underwent hepatectomy for colorectal liver metastasis in 32 French surgical centers. Repeat hepatectomies were excluded from the study. Based on a 1:4 propensity score matching model, 42 patients aged = 80 (OG) were matched with 168 patients 80 years (YG) in order to obtain 2 well-balanced and homogeneous groups with regards to therapy and prognostic factors. Results: The unmatched cohort consisted of 744 patients (OG: n = 42; YG: n = 702). After PS matching, there was no difference in terms of general morbidity, rates of Dindo-Clavien score AI (OG: 16% vs. YG: 21%, p = 0.663), surgical morbidity (OG: 16% vs. YG: 21%, p = 0.663), reoperation (OG:10% vs. YG: 5%, p = 0.263), 90-day mortality (OG:0% vs. YG:2%, p = 1), and total median hospital stay (OG: 12 vs. YG: 12, p = 0.972). Both groups experienced similar 3- and 5-year overall survival (82 and 82% OG vs.78 and 67% YG) and disease-free survival (40 and 35% OG vs. 45 and 35% YG at 3 and 5 years). Conclusions: No difference in perioperative and postoperative outcomes and disease-free and overall survival was found. Major hepatectomy in selected octogenarian patients is safe and feasible. (C) 2018 S. Karger AG, Basel
机译:背景:本研究的目的是评估老年结直肠癌患者转移的主要肝切除术的结果,其中有限的数据存在于文献中。方法:2006年1月至2013年1月,3,034名患者接受了32名法国外科中心的结肠直肠肝脏转移术后肝切除术。重复肝切除术被排除在研究之外。基于1:4倾向得分匹配模型,42例患者≥80(OG)与168名患者匹配,以获得240岁(YG),以获得治疗和预后的2种均衡和均匀的群体因素。结果:无与伦比的队列由744名患者组成(og:n = 42; yg:n = 702)。 PS匹配后,一般发病率没有差异,Dindo-Clavien评分AI的率(OG:16%与YG:21%,P = 0.663),手术发病率(OG:16%与YG:21 %,p = 0.663),再创率(og:10%与yg:5%,p = 0.263),90天死亡率(og:0%与yg:2%,p = 1)和总中位医院逗留(og:12 vs. yg:12,p = 0.972)。两组两组经历了相似的3-和5年的总体存活(82%和82%的OG与67%和67%的YG)和无病生存(40和35%OG与35%和35%YG) 。结论:发现围手术期和术后结果和无疾病和整体存活的差异。选定的八仙生物患者中的主要肝切除术是安全可行的。 (c)2018年S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号